Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2) - Graves, J E; Nunley, K; Heffernan, M P (J Am Acad Dermatol, 2007)